GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (FRA:6UI) » Definitions » Inventories, Finished Goods

Arecor Therapeutics (FRA:6UI) Inventories, Finished Goods : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics Inventories, Finished Goods?

Arecor Therapeutics's quarterly finished goods increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.56 Mil) but then declined from Dec. 2023 (€0.56 Mil) to Jun. 2024 (€0.00 Mil).

Arecor Therapeutics's annual finished goods increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.47 Mil) and increased from Dec. 2022 (€0.47 Mil) to Dec. 2023 (€0.56 Mil).

Arecor Therapeutics Inventories, Finished Goods Historical Data

The historical data trend for Arecor Therapeutics's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arecor Therapeutics Inventories, Finished Goods Chart

Arecor Therapeutics Annual Data
Trend May17 May18 May19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial - - - 0.47 0.56

Arecor Therapeutics Semi-Annual Data
May18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 0.47 - 0.56 -

Arecor Therapeutics Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Arecor Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (FRA:6UI) » Definitions » Inventories, Finished Goods
Comparable Companies
LSE:ETX LSE:4BB LSE:DEST LSE:SBTX LSE:OBD LSE:SAR LSE:TRX LSE:C4XD LSE:FUM LSE:POLB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
AREC:UK
Address
Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL
Website
https://www.arecor.com
Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, Germany, Italy, the Rest of Europe, the USA, and India, out of which the majority is from the UK.

Arecor Therapeutics Headlines

No Headlines